BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10334922)

  • 1. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
    Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
    Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.
    Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Shima N; Morinaga T; Chikazu D; Kawaguchi H; Higashio K
    Biochem Biophys Res Commun; 1999 Nov; 265(1):158-63. PubMed ID: 10548507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
    Tai H; Miyaura C; Pilbeam CC; Tamura T; Ohsugi Y; Koishihara Y; Kubodera N; Kawaguchi H; Raisz LG; Suda T
    Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Chikatsu N; Takeuchi Y; Tamura Y; Fukumoto S; Yano K; Tsuda E; Ogata E; Fujita T
    Biochem Biophys Res Commun; 2000 Jan; 267(2):632-7. PubMed ID: 10631114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin 1alpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol.
    Morisset S; Patry C; Lora M; de Brum-Fernandes AJ
    J Rheumatol; 1998 Jun; 25(6):1146-53. PubMed ID: 9632078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
    J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
    Gao YH; Shinki T; Yuasa T; Kataoka-Enomoto H; Komori T; Suda T; Yamaguchi A
    Biochem Biophys Res Commun; 1998 Nov; 252(3):697-702. PubMed ID: 9837769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells.
    Deyama Y; Takeyama S; Koshikawa M; Shirai Y; Yoshimura Y; Nishikata M; Suzuki K; Matsumoto A
    Biochem Biophys Res Commun; 2000 Jul; 274(1):249-54. PubMed ID: 10903926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor.
    Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Yamaguchi K; Shima N; Morinaga T; Higashio K
    Biochem Biophys Res Commun; 1999 Nov; 265(1):45-50. PubMed ID: 10548488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
    Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
    Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis.
    Kanzaki H; Chiba M; Shimizu Y; Mitani H
    J Bone Miner Res; 2002 Feb; 17(2):210-20. PubMed ID: 11811551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.
    Murakami T; Yamamoto M; Ono K; Nishikawa M; Nagata N; Motoyoshi K; Akatsu T
    Biochem Biophys Res Commun; 1998 Nov; 252(3):747-52. PubMed ID: 9837778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast-like cell formation induced by interleukin-1 beta.
    Sato T; Morita I; Sakaguchi K; Nakahama KI; Smith WL; Dewitt DL; Murota SI
    J Bone Miner Res; 1996 Mar; 11(3):392-400. PubMed ID: 8852950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
    Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
    J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 alpha induced cyclooxygenase-2 expression in bone-derived endothelial cells.
    Nakagawa T; Fujita N; Oh-Hara T; Kurokawa T; Nakamura K; Tsuruo T
    J Cell Physiol; 1999 May; 179(2):226-32. PubMed ID: 10199562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines.
    Virdi AS; Cook LJ; Oreffo RO; Triffitt JT
    Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1237-46. PubMed ID: 9874511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
    Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T
    J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-beta 1 genes in normal human osteoblast-like cells.
    Zheng MH; Wood DJ; Wysocki S; Papadimitriou JM; Wang EA
    J Cell Physiol; 1994 Apr; 159(1):76-82. PubMed ID: 8138593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.